Low rate of severe-end-stage kidney disease after SABR for localised primary kidney cancer.
Ali M, Koo K, Chang D, Chan P, Oon SF, Moon D, Murphy DG, Eapen R, Goad J, Lawrentschuk N, Azad AA, Chander S, Shaw M, Hardcastle N, Siva S.
Ali M, et al. Among authors: siva s.
Radiat Oncol. 2024 Feb 15;19(1):23. doi: 10.1186/s13014-024-02413-w.
Radiat Oncol. 2024.
PMID: 38355495
Free PMC article.